⤷ Title: CRISPR vs. Cholesterol: Single-Dose Gene Editing Eliminates Major Heart Disease Risk Factors
════════════════════════
𐀪 Author: ddos
════════════════════════
ⴵ Time: Mon, 01 Dec 2025 03:21:29 +0000
════════════════════════
⌗ Tags: #Technology #AHA 2025 #Cardiovascular Disease #Cholesterol #CRISPR #Epigenomic Editing #Gene Editing #PCSK9 #Scribe Therapeutics #Single_Dose Therapy
════════════════════════
𐀪 Author: ddos
════════════════════════
ⴵ Time: Mon, 01 Dec 2025 03:21:29 +0000
════════════════════════
⌗ Tags: #Technology #AHA 2025 #Cardiovascular Disease #Cholesterol #CRISPR #Epigenomic Editing #Gene Editing #PCSK9 #Scribe Therapeutics #Single_Dose Therapy
Penetration Testing Tools
CRISPR vs. Cholesterol: Single-Dose Gene Editing Eliminates Major Heart Disease Risk Factors
The CRISPR gene-editing system has now reached one of the principal drivers of cardiovascular disease: dangerous blood lipids.